BOSTON--(BUSINESS WIRE)--

The Biotechnology Industry Organization (BIO) today unveiled several new opinion surveys at the 2012 BIO International Convention, taking place this week in Boston. The surveys - conducted by the bipartisan pairing of Public Opinion Strategies and Hart Research Associates - found:

"These survey results are clear: The American people want policymakers to support cutting-edge research that will enable biotechnology to fulfill its potential to heal, fuel and feed the world, said Jim Greenwood, President and CEO of BIO. We are at a critical crossroads. We need policies in place that support investment in biotech innovation and a more streamlined regulatory process that properly protects patient safety and speeds the delivery of breakthrough medicines and cures to sick patients or we risk losing Americas leadership in biotech innovation.

The research included a survey of national voter attitudes, a survey of biotechnology executives and a third survey examining the attitudes of those attending the 2012 BIO International Convention.

Biotechnology Executives Concerned About Regulatory Burdens, Less Optimistic

The survey of executives at BIO members companies found these industry leaders believe government regulation has had a negative impact on the biotech industry and this is largely unchanged compared to a survey conducted on behalf of BIO five years ago (58 percent today vs. 56 percent in 2007). They are less optimistic today than they were in 2007 (63 percent compared to 79 percent) that, in the future, the biotechnology industry will continue to develop new therapeutics and products to help address global needs in healthcare, agriculture, energy and the environment.

When compared to BIOs 2007 survey, todays industry executives reported the following:

Other key findings in the research include:

Methodology

The national surveys of N=169 BIO member company executives and of N=800 registered voters were conducted May 14-24 and May 20-23, 2012, respectively, by Public Opinion Strategies and Peter D. Hart Research Associates on behalf of the Biotechnology Industry Organization.

Link:
Americans and Biotechnology Executives Remain Optimistic About Future of Biotechnology Despite Serious Industry ...